Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline in Eisenmenger Syndrome
NCT05611268Recruiting
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Jun 2022
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of pentoxifylline in Eisenmenger syndrome (2 arms), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Primary endpoint: Plasma concentration of Thrombomodulin at 6 months. Started Jun 2022; status: recruiting.
02
Drugs
pentoxifylline
03
Conditions
Eisenmenger syndrome
Beyond the preview
Go deeper on NCT05611268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05611268.